{"transactions":[{"id":1358369,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-19T23:26:27.000Z","date":"2024-11-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11937,"price":6.175,"value":73710.975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1487694,"source":{"system":"sec-edgar","filing":"0001601830-24-000214","document":"wk-form4_1732058781.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000214/wk-form4_1732058781.xml","form_type":"4"}},{"id":1364731,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-15T00:19:38.000Z","date":"2024-11-13","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":337635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000204","document":"wk-form4_1731629971.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000204/wk-form4_1731629971.xml","form_type":"4"}},{"id":1364730,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-15T00:19:38.000Z","date":"2024-11-12","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":377010,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000204","document":"wk-form4_1731629971.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000204/wk-form4_1731629971.xml","form_type":"4"}},{"id":1364729,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-15T00:19:38.000Z","date":"2024-11-13","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":7.6584,"value":114876.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.31 to $7.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1499631,"source":{"system":"sec-edgar","filing":"0001601830-24-000204","document":"wk-form4_1731629971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000204/wk-form4_1731629971.xml","form_type":"4"}},{"id":1364728,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-15T00:19:38.000Z","date":"2024-11-13","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1514631,"source":{"system":"sec-edgar","filing":"0001601830-24-000204","document":"wk-form4_1731629971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000204/wk-form4_1731629971.xml","form_type":"4"}},{"id":1364727,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-15T00:19:38.000Z","date":"2024-11-12","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":7.6419,"value":114628.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.49 to $8.01 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1475256,"source":{"system":"sec-edgar","filing":"0001601830-24-000204","document":"wk-form4_1731629971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000204/wk-form4_1731629971.xml","form_type":"4"}},{"id":1364726,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-15T00:19:38.000Z","date":"2024-11-12","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1490256,"source":{"system":"sec-edgar","filing":"0001601830-24-000204","document":"wk-form4_1731629971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000204/wk-form4_1731629971.xml","form_type":"4"}},{"id":1387986,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-10T22:40:44.000Z","date":"2024-10-09","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":416385,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000176","document":"wk-form4_1728600038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000176/wk-form4_1728600038.xml","form_type":"4"}},{"id":1387985,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-10T22:40:44.000Z","date":"2024-10-08","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":455760,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000176","document":"wk-form4_1728600038.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000176/wk-form4_1728600038.xml","form_type":"4"}},{"id":1387984,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-10-10T22:40:44.000Z","date":"2024-10-09","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":6.3583,"value":95374.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $6.095 to $6.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1450881,"source":{"system":"sec-edgar","filing":"0001601830-24-000176","document":"wk-form4_1728600038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000176/wk-form4_1728600038.xml","form_type":"4"}},{"id":1387983,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-10-10T22:40:44.000Z","date":"2024-10-09","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1465881,"source":{"system":"sec-edgar","filing":"0001601830-24-000176","document":"wk-form4_1728600038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000176/wk-form4_1728600038.xml","form_type":"4"}},{"id":1387982,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-10-10T22:40:44.000Z","date":"2024-10-08","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":6.3171,"value":94756.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.17 to $6.48 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1426506,"source":{"system":"sec-edgar","filing":"0001601830-24-000176","document":"wk-form4_1728600038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000176/wk-form4_1728600038.xml","form_type":"4"}},{"id":1387981,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-10-10T22:40:44.000Z","date":"2024-10-08","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1441506,"source":{"system":"sec-edgar","filing":"0001601830-24-000176","document":"wk-form4_1728600038.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000176/wk-form4_1728600038.xml","form_type":"4"}},{"id":1408343,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-12T22:28:34.000Z","date":"2024-09-11","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":495135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000156","document":"wk-form4_1726180107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000156/wk-form4_1726180107.xml","form_type":"4"}},{"id":1408342,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-12T22:28:34.000Z","date":"2024-09-10","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":534510,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000156","document":"wk-form4_1726180107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000156/wk-form4_1726180107.xml","form_type":"4"}},{"id":1408341,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-12T22:28:34.000Z","date":"2024-09-11","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":6.3153,"value":94729.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $6.18 to $6.50 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1402131,"source":{"system":"sec-edgar","filing":"0001601830-24-000156","document":"wk-form4_1726180107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000156/wk-form4_1726180107.xml","form_type":"4"}},{"id":1408340,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-12T22:28:34.000Z","date":"2024-09-11","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1417131,"source":{"system":"sec-edgar","filing":"0001601830-24-000156","document":"wk-form4_1726180107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000156/wk-form4_1726180107.xml","form_type":"4"}},{"id":1408339,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-12T22:28:34.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":6.1666,"value":92499.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.06 to $6.31 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1377756,"source":{"system":"sec-edgar","filing":"0001601830-24-000156","document":"wk-form4_1726180107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000156/wk-form4_1726180107.xml","form_type":"4"}},{"id":1408338,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-09-12T22:28:34.000Z","date":"2024-09-10","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1392756,"source":{"system":"sec-edgar","filing":"0001601830-24-000156","document":"wk-form4_1726180107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000156/wk-form4_1726180107.xml","form_type":"4"}},{"id":1428818,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-19T23:09:22.000Z","date":"2024-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11962,"price":6.69,"value":80025.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1353381,"source":{"system":"sec-edgar","filing":"0001601830-24-000125","document":"wk-form4_1724108956.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000125/wk-form4_1724108956.xml","form_type":"4"}},{"id":1432221,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-15T21:24:09.000Z","date":"2024-08-14","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":573885,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000123","document":"wk-form4_1723757043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000123/wk-form4_1723757043.xml","form_type":"4"}},{"id":1432220,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-15T21:24:09.000Z","date":"2024-08-13","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":613260,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000123","document":"wk-form4_1723757043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000123/wk-form4_1723757043.xml","form_type":"4"}},{"id":1432219,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-15T21:24:09.000Z","date":"2024-08-14","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":6.3501,"value":95251.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $6.26 to $6.66 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1365343,"source":{"system":"sec-edgar","filing":"0001601830-24-000123","document":"wk-form4_1723757043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000123/wk-form4_1723757043.xml","form_type":"4"}},{"id":1432218,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-15T21:24:09.000Z","date":"2024-08-14","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1380343,"source":{"system":"sec-edgar","filing":"0001601830-24-000123","document":"wk-form4_1723757043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000123/wk-form4_1723757043.xml","form_type":"4"}},{"id":1432217,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-15T21:24:09.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":6.3455,"value":95182.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.04 to $6.56 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1340968,"source":{"system":"sec-edgar","filing":"0001601830-24-000123","document":"wk-form4_1723757043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000123/wk-form4_1723757043.xml","form_type":"4"}},{"id":1432216,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-15T21:24:09.000Z","date":"2024-08-13","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1355968,"source":{"system":"sec-edgar","filing":"0001601830-24-000123","document":"wk-form4_1723757043.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000123/wk-form4_1723757043.xml","form_type":"4"}},{"id":1455854,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-11T20:51:47.000Z","date":"2024-07-10","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":652635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000101","document":"wk-form4_1720731099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000101/wk-form4_1720731099.xml","form_type":"4"}},{"id":1455853,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-11T20:51:47.000Z","date":"2024-07-09","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":692010,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000101","document":"wk-form4_1720731099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000101/wk-form4_1720731099.xml","form_type":"4"}},{"id":1455852,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-07-11T20:51:47.000Z","date":"2024-07-10","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":7.2384,"value":108576.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.155 to $7.50 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1316593,"source":{"system":"sec-edgar","filing":"0001601830-24-000101","document":"wk-form4_1720731099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000101/wk-form4_1720731099.xml","form_type":"4"}},{"id":1455851,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-07-11T20:51:47.000Z","date":"2024-07-10","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1331593,"source":{"system":"sec-edgar","filing":"0001601830-24-000101","document":"wk-form4_1720731099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000101/wk-form4_1720731099.xml","form_type":"4"}},{"id":1455850,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-07-11T20:51:47.000Z","date":"2024-07-09","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":7.3185,"value":109777.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.165 to $7.44 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1292218,"source":{"system":"sec-edgar","filing":"0001601830-24-000101","document":"wk-form4_1720731099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000101/wk-form4_1720731099.xml","form_type":"4"}},{"id":1455849,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-07-11T20:51:47.000Z","date":"2024-07-09","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1307218,"source":{"system":"sec-edgar","filing":"0001601830-24-000101","document":"wk-form4_1720731099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000101/wk-form4_1720731099.xml","form_type":"4"}},{"id":1476860,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-17T21:46:49.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":731385,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000083","document":"wk-form4_1718660802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000083/wk-form4_1718660802.xml","form_type":"4"}},{"id":1476859,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-17T21:46:49.000Z","date":"2024-06-13","kind":"exercise","planned":true,"acquired":false,"shares":39375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":770760,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":39375},"source":{"system":"sec-edgar","filing":"0001601830-24-000083","document":"wk-form4_1718660802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000083/wk-form4_1718660802.xml","form_type":"4"}},{"id":1476858,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-17T21:46:49.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":9.2721,"value":139081.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.185 to $9.39 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1267843,"source":{"system":"sec-edgar","filing":"0001601830-24-000083","document":"wk-form4_1718660802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000083/wk-form4_1718660802.xml","form_type":"4"}},{"id":1476857,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-17T21:46:49.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1282843,"source":{"system":"sec-edgar","filing":"0001601830-24-000083","document":"wk-form4_1718660802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000083/wk-form4_1718660802.xml","form_type":"4"}},{"id":1476856,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-17T21:46:49.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":9.3199,"value":139798.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.125 to $9.47 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1243468,"source":{"system":"sec-edgar","filing":"0001601830-24-000083","document":"wk-form4_1718660802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000083/wk-form4_1718660802.xml","form_type":"4"}},{"id":1476855,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-17T21:46:49.000Z","date":"2024-06-13","kind":"exercise","planned":true,"acquired":true,"shares":39375,"price":2.22,"value":87412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2024."}],"balance_after":1258468,"source":{"system":"sec-edgar","filing":"0001601830-24-000083","document":"wk-form4_1718660802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000083/wk-form4_1718660802.xml","form_type":"4"}},{"id":1510510,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-05-17T23:11:41.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11962,"price":10.01,"value":119739.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.44 to $7.70 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1219093,"source":{"system":"sec-edgar","filing":"0001601830-24-000056","document":"wk-form4_1715987475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000056/wk-form4_1715987475.xml","form_type":"4"}},{"id":1539083,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-18T21:12:22.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":810135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001601830-24-000036","document":"wk-form4_1713474733.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000036/wk-form4_1713474733.xml","form_type":"4"}},{"id":1539082,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-18T21:12:22.000Z","date":"2024-04-16","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":847635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001601830-24-000036","document":"wk-form4_1713474733.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000036/wk-form4_1713474733.xml","form_type":"4"}},{"id":1539081,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-04-18T21:12:22.000Z","date":"2024-04-17","kind":"sale","planned":true,"acquired":false,"shares":23124,"price":7.583,"value":175349.292,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.44 to $7.70 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1231055,"source":{"system":"sec-edgar","filing":"0001601830-24-000036","document":"wk-form4_1713474733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000036/wk-form4_1713474733.xml","form_type":"4"}},{"id":1539080,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-04-18T21:12:22.000Z","date":"2024-04-17","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":1254179,"source":{"system":"sec-edgar","filing":"0001601830-24-000036","document":"wk-form4_1713474733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000036/wk-form4_1713474733.xml","form_type":"4"}},{"id":1539079,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-04-18T21:12:22.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":7.6663,"value":191657.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.54 to $7.77 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1216679,"source":{"system":"sec-edgar","filing":"0001601830-24-000036","document":"wk-form4_1713474733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000036/wk-form4_1713474733.xml","form_type":"4"}},{"id":1539078,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-04-18T21:12:22.000Z","date":"2024-04-16","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":1241679,"source":{"system":"sec-edgar","filing":"0001601830-24-000036","document":"wk-form4_1713474733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000036/wk-form4_1713474733.xml","form_type":"4"}},{"id":1576224,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-14T23:28:45.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":885135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001601830-24-000023","document":"wk-form4_1710458910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000023/wk-form4_1710458910.xml","form_type":"4"}},{"id":1576223,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-14T23:28:45.000Z","date":"2024-03-12","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":922635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001601830-24-000023","document":"wk-form4_1710458910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000023/wk-form4_1710458910.xml","form_type":"4"}},{"id":1576222,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-14T23:28:45.000Z","date":"2024-03-13","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":11.0326,"value":275815.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $10.98 to $11.33 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1204179,"source":{"system":"sec-edgar","filing":"0001601830-24-000023","document":"wk-form4_1710458910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000023/wk-form4_1710458910.xml","form_type":"4"}},{"id":1576221,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-14T23:28:45.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":1229179,"source":{"system":"sec-edgar","filing":"0001601830-24-000023","document":"wk-form4_1710458910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000023/wk-form4_1710458910.xml","form_type":"4"}},{"id":1576220,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-14T23:28:45.000Z","date":"2024-03-12","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":10.455,"value":261375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.21 to $10.67 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1191679,"source":{"system":"sec-edgar","filing":"0001601830-24-000023","document":"wk-form4_1710458910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000023/wk-form4_1710458910.xml","form_type":"4"}},{"id":1576219,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-14T23:28:45.000Z","date":"2024-03-12","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":1216679,"source":{"system":"sec-edgar","filing":"0001601830-24-000023","document":"wk-form4_1710458910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000160183024000023/wk-form4_1710458910.xml","form_type":"4"}},{"id":1637532,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-17T00:59:37.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7172,"price":12.43,"value":89147.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1179179,"source":{"system":"sec-edgar","filing":"0001209191-24-003489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003489/doc4.xml","form_type":"4"}},{"id":1640555,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-15T23:00:13.000Z","date":"2024-02-14","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":960135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-24-003410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003410/doc4.xml","form_type":"4"}},{"id":1640554,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-15T23:00:13.000Z","date":"2024-02-13","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":997635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-24-003410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003410/doc4.xml","form_type":"4"}},{"id":1640553,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-15T23:00:13.000Z","date":"2024-02-14","kind":"sale","planned":true,"acquired":false,"shares":1067,"price":10.9841,"value":11720.0347,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $10.925 to $11.015. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1186351,"source":{"system":"sec-edgar","filing":"0001209191-24-003410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003410/doc4.xml","form_type":"4"}},{"id":1640552,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-15T23:00:13.000Z","date":"2024-02-14","kind":"sale","planned":true,"acquired":false,"shares":23933,"price":10.4335,"value":249704.9555,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.92 to $10.905. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1187418,"source":{"system":"sec-edgar","filing":"0001209191-24-003410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003410/doc4.xml","form_type":"4"}},{"id":1640551,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-15T23:00:13.000Z","date":"2024-02-14","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":1211351,"source":{"system":"sec-edgar","filing":"0001209191-24-003410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003410/doc4.xml","form_type":"4"}},{"id":1640550,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-15T23:00:13.000Z","date":"2024-02-13","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":9.8624,"value":246560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.635 to $10.16 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":1173851,"source":{"system":"sec-edgar","filing":"0001209191-24-003410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003410/doc4.xml","form_type":"4"}},{"id":1640549,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-15T23:00:13.000Z","date":"2024-02-13","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":1198851,"source":{"system":"sec-edgar","filing":"0001209191-24-003410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003410/doc4.xml","form_type":"4"}},{"id":1645340,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T00:01:59.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":348380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter."}],"balance_after":348380,"derivative":{"exercise_price":10.09,"expiration_date":"2034-02-09","underlying":"Class A Common Stock","underlying_shares":348380},"source":{"system":"sec-edgar","filing":"0001209191-24-003238","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003238/doc4.xml","form_type":"4"}},{"id":1645339,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-14T00:01:59.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2512,"price":10.09,"value":25346.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1161351,"source":{"system":"sec-edgar","filing":"0001209191-24-003238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003238/doc4.xml","form_type":"4"}},{"id":1645338,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-14T00:01:59.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":174190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2024 and every three months thereafter."}],"balance_after":1163863,"source":{"system":"sec-edgar","filing":"0001209191-24-003238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003238/doc4.xml","form_type":"4"}},{"id":1645337,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-14T00:01:59.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":8659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vested immediately upon the grant date."}],"balance_after":989673,"source":{"system":"sec-edgar","filing":"0001209191-24-003238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124003238/doc4.xml","form_type":"4"}},{"id":1676040,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T23:37:33.000Z","date":"2024-01-17","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1035135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-24-001868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001868/doc4.xml","form_type":"4"}},{"id":1676039,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T23:37:33.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1072635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-24-001868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001868/doc4.xml","form_type":"4"}},{"id":1676038,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T23:37:33.000Z","date":"2024-01-17","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":10.2539,"value":256347.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $10.08 to $10.53 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":981014,"source":{"system":"sec-edgar","filing":"0001209191-24-001868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001868/doc4.xml","form_type":"4"}},{"id":1676037,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T23:37:33.000Z","date":"2024-01-17","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":1006014,"source":{"system":"sec-edgar","filing":"0001209191-24-001868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001868/doc4.xml","form_type":"4"}},{"id":1676036,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T23:37:33.000Z","date":"2024-01-16","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":10.4464,"value":261160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.01 to $10.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":968514,"source":{"system":"sec-edgar","filing":"0001209191-24-001868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001868/doc4.xml","form_type":"4"}},{"id":1676035,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-01-18T23:37:33.000Z","date":"2024-01-16","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":993514,"source":{"system":"sec-edgar","filing":"0001209191-24-001868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919124001868/doc4.xml","form_type":"4"}},{"id":1710635,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-14T23:53:13.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1110135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-058703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123058703/doc4.xml","form_type":"4"}},{"id":1710634,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-14T23:53:13.000Z","date":"2023-12-12","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1147635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-058703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123058703/doc4.xml","form_type":"4"}},{"id":1710633,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-14T23:53:13.000Z","date":"2023-12-13","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":7.5908,"value":189770.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.34 to $8.30 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":956014,"source":{"system":"sec-edgar","filing":"0001209191-23-058703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123058703/doc4.xml","form_type":"4"}},{"id":1710632,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-14T23:53:13.000Z","date":"2023-12-13","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":981014,"source":{"system":"sec-edgar","filing":"0001209191-23-058703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123058703/doc4.xml","form_type":"4"}},{"id":1710631,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-14T23:53:13.000Z","date":"2023-12-12","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":7.3947,"value":184867.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $7.265 to $7.53. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":943514,"source":{"system":"sec-edgar","filing":"0001209191-23-058703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123058703/doc4.xml","form_type":"4"}},{"id":1710630,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-14T23:53:13.000Z","date":"2023-12-12","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":968514,"source":{"system":"sec-edgar","filing":"0001209191-23-058703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123058703/doc4.xml","form_type":"4"}},{"id":1738641,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-16T23:54:07.000Z","date":"2023-11-15","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1185135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-055610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055610/doc4.xml","form_type":"4"}},{"id":1738640,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-16T23:54:07.000Z","date":"2023-11-14","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1222635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-055610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055610/doc4.xml","form_type":"4"}},{"id":1738639,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-16T23:54:07.000Z","date":"2023-11-15","kind":"tax_withholding","planned":true,"acquired":false,"shares":7172,"price":7.18,"value":51494.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":931014,"source":{"system":"sec-edgar","filing":"0001209191-23-055610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055610/doc4.xml","form_type":"4"}},{"id":1738638,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-16T23:54:07.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":4700,"price":7.6168,"value":35798.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $7.51 to $7.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":938186,"source":{"system":"sec-edgar","filing":"0001209191-23-055610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055610/doc4.xml","form_type":"4"}},{"id":1738637,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-16T23:54:07.000Z","date":"2023-11-15","kind":"sale","planned":true,"acquired":false,"shares":20300,"price":7.2506,"value":147187.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $6.51 to $7.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":942886,"source":{"system":"sec-edgar","filing":"0001209191-23-055610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055610/doc4.xml","form_type":"4"}},{"id":1738636,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-16T23:54:07.000Z","date":"2023-11-15","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":963186,"source":{"system":"sec-edgar","filing":"0001209191-23-055610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055610/doc4.xml","form_type":"4"}},{"id":1738635,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-16T23:54:07.000Z","date":"2023-11-14","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":6.3177,"value":157942.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.13 to $6.485. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":925686,"source":{"system":"sec-edgar","filing":"0001209191-23-055610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055610/doc4.xml","form_type":"4"}},{"id":1738634,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-16T23:54:07.000Z","date":"2023-11-14","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":950686,"source":{"system":"sec-edgar","filing":"0001209191-23-055610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123055610/doc4.xml","form_type":"4"}},{"id":1760974,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-12T22:07:29.000Z","date":"2023-10-11","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1260135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-052716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123052716/doc4.xml","form_type":"4"}},{"id":1760973,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-12T22:07:29.000Z","date":"2023-10-10","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1297635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-052716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123052716/doc4.xml","form_type":"4"}},{"id":1760972,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-12T22:07:29.000Z","date":"2023-10-11","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":6.8525,"value":171312.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $6.72 to $7.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":913186,"source":{"system":"sec-edgar","filing":"0001209191-23-052716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123052716/doc4.xml","form_type":"4"}},{"id":1760971,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-12T22:07:29.000Z","date":"2023-10-11","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":938186,"source":{"system":"sec-edgar","filing":"0001209191-23-052716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123052716/doc4.xml","form_type":"4"}},{"id":1760970,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-12T22:07:29.000Z","date":"2023-10-10","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":7.0705,"value":176762.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.78 to $7.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":900686,"source":{"system":"sec-edgar","filing":"0001209191-23-052716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123052716/doc4.xml","form_type":"4"}},{"id":1760969,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-10-12T22:07:29.000Z","date":"2023-10-10","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":925686,"source":{"system":"sec-edgar","filing":"0001209191-23-052716","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123052716/doc4.xml","form_type":"4"}},{"id":1780801,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-14T22:26:46.000Z","date":"2023-09-13","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1335135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-049478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123049478/doc4.xml","form_type":"4"}},{"id":1780800,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-14T22:26:46.000Z","date":"2023-09-12","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1372635,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-049478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123049478/doc4.xml","form_type":"4"}},{"id":1780799,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-14T22:26:46.000Z","date":"2023-09-13","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":8.6927,"value":217317.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $8.52 to $8.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":888186,"source":{"system":"sec-edgar","filing":"0001209191-23-049478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123049478/doc4.xml","form_type":"4"}},{"id":1780798,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-14T22:26:46.000Z","date":"2023-09-13","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":913186,"source":{"system":"sec-edgar","filing":"0001209191-23-049478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123049478/doc4.xml","form_type":"4"}},{"id":1780797,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-14T22:26:46.000Z","date":"2023-09-12","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":8.4253,"value":210632.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.23 to $8.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":875686,"source":{"system":"sec-edgar","filing":"0001209191-23-049478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123049478/doc4.xml","form_type":"4"}},{"id":1780796,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-14T22:26:46.000Z","date":"2023-09-12","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":900686,"source":{"system":"sec-edgar","filing":"0001209191-23-049478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123049478/doc4.xml","form_type":"4"}},{"id":1802915,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T22:35:43.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1410135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-046423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046423/doc4.xml","form_type":"4"}},{"id":1802914,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-17T22:35:43.000Z","date":"2023-08-15","kind":"exercise","planned":true,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events."}],"balance_after":1485135,"derivative":{"exercise_price":2.22,"expiration_date":"2030-03-03","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-23-046423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046423/doc4.xml","form_type":"4"}},{"id":1802913,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-17T22:35:43.000Z","date":"2023-08-16","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":8.9007,"value":222517.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $8.66 to $9.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":863186,"source":{"system":"sec-edgar","filing":"0001209191-23-046423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046423/doc4.xml","form_type":"4"}},{"id":1802912,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-17T22:35:43.000Z","date":"2023-08-16","kind":"exercise","planned":true,"acquired":true,"shares":37500,"price":2.22,"value":83250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."}],"balance_after":888186,"source":{"system":"sec-edgar","filing":"0001209191-23-046423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046423/doc4.xml","form_type":"4"}},{"id":1802911,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":85900,"kind":"person","name":"Secora Michael","position":1,"cik":"0001855980","reported_name":"Secora Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-17T22:35:43.000Z","date":"2023-08-15","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":9.2717,"value":231792.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction is pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.14 to $9.55. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":850686,"source":{"system":"sec-edgar","filing":"0001209191-23-046423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601830/000120919123046423/doc4.xml","form_type":"4"}}],"next_cursor":"2023-08-17T22:35:43.000000Z,1802911"}